drugset / Trial / NCT05496569
TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
RandomizedParallel-groupTriple-blindTreatment
Summary
A clinical trial evaluating TQB3616 capsules versus placebo in the treatment of dedifferentiated liposarcoma. Divided into 2 stages, the second stage, a total of 118 subjects are planned to be enrolled.
Timeline
- Start
- 2022-08-08
- Primary completion
- 2024-06-15
- Completion
- 2025-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQB3616 | Small molecule | 180 mg | Oral |